Nalaganje...
New insights into acquired endocrine resistance of breast cancer
The translational research strategy of targeting estrogen receptor α (ERα) positive breast cancer and then using long term anti-hormone adjuvant therapy (5-10 years) has reduced recurrences and mortality. However, resistance continues to occur and improvements are required to build on the success of...
Shranjeno v:
| izdano v: | Cancer Drug Resist |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
OAE Publishing Inc.
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6897388/ https://ncbi.nlm.nih.gov/pubmed/31815253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/cdr.2019.13 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|